HENDERSON MICHAEL THOMAS
Chief Executive Officer · 41 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | APGE | Apogee Therapeutics, Inc. | Gift | 75,046 | $0.00 | $0.00 | filing |
| 2026-07-08 | APGE | Apogee Therapeutics, Inc. | Sale | 20,000 | $133.63 | $2.7M | filing |
| 2026-06-22 | APGE | Apogee Therapeutics, Inc. | Sale | 80,000 | $132.54 | $10.6M | filing |
| 2026-06-22 | SYRE | Spyre Therapeutics, Inc. | Sale | 20,000 | $100.00 | $2.0M | filing |
| 2026-06-10 | APGE | Apogee Therapeutics, Inc. | Sale | 7,654 | $82.78 | $633,598.12 | filing |
| 2026-06-10 | APGE | Apogee Therapeutics, Inc. | Sale | 6,770 | $82.21 | $556,561.70 | filing |
| 2026-06-10 | APGE | Apogee Therapeutics, Inc. | Sale | 2,305 | $86.27 | $198,852.35 | filing |
| 2026-06-10 | APGE | Apogee Therapeutics, Inc. | Sale | 1,577 | $85.19 | $134,344.63 | filing |
| 2026-06-10 | APGE | Apogee Therapeutics, Inc. | Sale | 1,080 | $84.18 | $90,914.40 | filing |
| 2026-06-10 | APGE | Apogee Therapeutics, Inc. | Sale | 614 | $86.89 | $53,350.46 | filing |
| 2026-05-13 | APGE | Apogee Therapeutics, Inc. | Sale | 18,659 | $82.05 | $1.5M | filing |
| 2026-05-13 | APGE | Apogee Therapeutics, Inc. | Sale | 1,341 | $82.58 | $110,739.78 | filing |
| 2026-05-08 | SYRE | Spyre Therapeutics, Inc. | Sale | 33,513 | $73.72 | $2.5M | filing |
| 2026-05-08 | SYRE | Spyre Therapeutics, Inc. | Sale | 24,814 | $74.76 | $1.9M | filing |
| 2026-05-08 | SYRE | Spyre Therapeutics, Inc. | Sale | 19,269 | $75.35 | $1.5M | filing |
| 2026-05-08 | SYRE | Spyre Therapeutics, Inc. | Sale | 2,404 | $72.57 | $174,458.28 | filing |
| 2026-04-16 | APGE | Apogee Therapeutics, Inc. | Option exercise | 3,000 | $22.86 | $68,580.00 | filing |
| 2026-04-08 | APGE | Apogee Therapeutics, Inc. | Sale | 17,800 | $82.48 | $1.5M | filing |
| 2026-04-08 | APGE | Apogee Therapeutics, Inc. | Sale | 2,000 | $83.26 | $166,520.00 | filing |
| 2026-04-08 | APGE | Apogee Therapeutics, Inc. | Sale | 200 | $85.00 | $17,000.00 | filing |
| 2026-03-11 | APGE | Apogee Therapeutics, Inc. | Sale | 8,363 | $74.29 | $621,287.27 | filing |
| 2026-03-11 | APGE | Apogee Therapeutics, Inc. | Sale | 8,219 | $74.83 | $615,027.77 | filing |
| 2026-03-11 | APGE | Apogee Therapeutics, Inc. | Sale | 3,418 | $75.86 | $259,289.48 | filing |
| 2026-02-11 | APGE | Apogee Therapeutics, Inc. | Sale | 11,494 | $62.96 | $723,662.24 | filing |
| 2026-02-11 | APGE | Apogee Therapeutics, Inc. | Sale | 7,551 | $63.73 | $481,225.23 | filing |
| 2026-02-11 | APGE | Apogee Therapeutics, Inc. | Sale | 955 | $64.99 | $62,065.45 | filing |
| 2026-01-21 | SYRE | Spyre Therapeutics, Inc. | J | 63,227 | $0.00 | $0.00 | filing |
| 2026-01-14 | APGE | Apogee Therapeutics, Inc. | Sale | 8,476 | $79.82 | $676,554.32 | filing |
| 2026-01-14 | APGE | Apogee Therapeutics, Inc. | Sale | 5,386 | $83.16 | $447,899.76 | filing |
| 2026-01-14 | APGE | Apogee Therapeutics, Inc. | Sale | 2,374 | $81.00 | $192,294.00 | filing |
| 2026-01-14 | APGE | Apogee Therapeutics, Inc. | Sale | 1,854 | $82.41 | $152,788.14 | filing |
| 2026-01-14 | APGE | Apogee Therapeutics, Inc. | Sale | 1,440 | $78.64 | $113,241.60 | filing |
| 2026-01-14 | APGE | Apogee Therapeutics, Inc. | Sale | 470 | $83.79 | $39,381.30 | filing |
| 2025-12-10 | APGE | Apogee Therapeutics, Inc. | Sale | 10,005 | $75.79 | $758,278.95 | filing |
| 2025-12-10 | APGE | Apogee Therapeutics, Inc. | Sale | 9,435 | $74.88 | $706,492.80 | filing |
| 2025-12-10 | APGE | Apogee Therapeutics, Inc. | Sale | 560 | $76.58 | $42,884.80 | filing |
| 2025-12-04 | APGE | Apogee Therapeutics, Inc. | Sale | 40,000 | $75.01 | $3.0M | filing |
| 2025-11-13 | APGE | Apogee Therapeutics, Inc. | Sale | 14,774 | $63.14 | $932,830.36 | filing |
| 2025-11-13 | APGE | Apogee Therapeutics, Inc. | Sale | 3,340 | $61.93 | $206,846.20 | filing |
| 2025-11-13 | APGE | Apogee Therapeutics, Inc. | Sale | 1,786 | $63.89 | $114,107.54 | filing |
| 2025-11-13 | APGE | Apogee Therapeutics, Inc. | Sale | 100 | $64.52 | $6,452.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.